Dr Anna Sophie Berghoff presented new evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland. The novel research shows that brain metastases have dense concentrations of tumour infiltrating lymphocytes, providing an immunoactive environment. Moreover, both primary and secondary brain cancers often exhibit high expression of the immunosuppressive factor programmed ...Saturday 22 November 2014
Brain Cancers may be Tackled by Immune Checkpoint Inhibitors
Dr Anna Sophie Berghoff presented new evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland. The novel research shows that brain metastases have dense concentrations of tumour infiltrating lymphocytes, providing an immunoactive environment. Moreover, both primary and secondary brain cancers often exhibit high expression of the immunosuppressive factor programmed ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment